We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+28.63%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$461M
AUM Growth
–
Cap. Flow
+$414M
Cap. Flow
% of AUM
89.87%
Top 10 Holdings %
Top 10 Hldgs %
9.23%
Holding
309
New
309
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEAR
TearLab Corporation
TEAR
|
+$4.77M |
| 2 |
CAMP
CalAmp Corp.
CAMP
|
+$4.23M |
| 3 |
POWR
POWERSECURE INTL INC COM STK (DE)
POWR
|
+$4.11M |
| 4 |
HCI Group
HCI
|
+$3.9M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$3.87M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.34% |
| 2 | Technology | 18.82% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Industrials | 12.49% |
| 5 | Communication Services | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRGI
26
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $2.83M | 0.61% |
+82,178
| New | +$2.51M |
|
27
Entravision Communication
EVC
$1.01B
| $2.81M | 0.61% |
+456,125
| New | +$2.03M |
|
28
Acadia Pharmaceuticals
ACAD
$4.45B
| $2.76M | 0.6% |
+152,055
| New | +$2.09M |
|
|
AMRI
29
DELISTED
Albany Molecular Research Inc
AMRI
| $2.75M | 0.6% |
+232,102
| New | +$2.51M |
|
30
Immersion
IMMR
$254M
| $2.72M | 0.59% |
+205,027
| New | +$2.62M |
|
31
Methode Electronics
MEI
$525M
| $2.7M | 0.59% |
+158,630
| New | +$2.31M |
|
|
PSUN
32
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
| $2.66M | 0.58% |
+728,791
| New | +$2.1M |
|
33
Insteel Industries
IIIN
$631M
| $2.6M | 0.56% |
+148,162
| New | +$2.55M |
|
|
XONE
34
DELISTED
The ExOne Company
XONE
| $2.59M | 0.56% |
+42,010
| New | +$1.77M |
|
|
PFPT
35
DELISTED
Proofpoint, Inc.
PFPT
| $2.45M | 0.53% |
+100,985
| New | +$1.96M |
|
|
TUES
36
DELISTED
Tuesday Morning Corp
TUES
| $2.44M | 0.53% |
+235,604
| New | +$2.03M |
|
37
Neurocrine Biosciences
NBIX
$18.4B
| $2.42M | 0.52% |
+180,478
| New | +$2.22M |
|
38
Red Robin
RRGB
$139M
| $2.35M | 0.51% |
+42,624
| New | +$2.13M |
|
39
Cytokinetics
CYTK
$10.8B
| $2.34M | 0.51% |
+202,465
| New | +$1.59M |
|
40
Arq
ARQ
$83.7M
| $2.29M | 0.5% |
+108,570
| New | +$1.72M |
|
41
Repligen
RGEN
$7.11B
| $2.28M | 0.49% |
+276,691
| New | +$2.32M |
|
|
MOVE
42
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $2.27M | 0.49% |
+177,267
| New | +$2.01M |
|
|
SAAS
43
DELISTED
inContact, Inc.
SAAS
| $2.27M | 0.49% |
+276,077
| New | +$2.15M |
|
|
PLKI
44
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $2.26M | 0.49% |
+62,927
| New | +$2.15M |
|
|
APP
45
DELISTED
AMERICAN APPAREL INC COM
APP
| $2.23M | 0.48% |
+1,159,983
| New | +$2.28M |
|
46
Nexstar Media Group
NXST
$5.92B
| $2.22M | 0.48% |
+62,653
| New | +$1.65M |
|
|
TSRX
47
DELISTED
TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
| $2.2M | 0.48% |
+270,881
| New | +$2M |
|
48
Rambus
RMBS
$9.49B
| $2.2M | 0.48% |
+255,898
| New | +$1.91M |
|
|
STML
49
DELISTED
Stemline Therapeutics, Inc.
STML
| $2.15M | 0.47% |
+90,119
| New | +$1.44M |
|
50
Vanda Pharmaceuticals
VNDA
$310M
| $2.14M | 0.46% |
+265,012
| New | +$1.78M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for EAM Investors, which disclosed 309 positions worth $461M. Its ten largest holdings account for 9.2% of the portfolio.
Its largest position is TearLab Corporation: 52,195 shares worth $5.54M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Technology and Consumer Discretionary.
- EAM Investors's largest Q2 2013 buy was TearLab Corporation: 52,195 shares worth $5.54M.
- EAM Investors's ten largest holdings make up 9.2% of its $461M portfolio in Q2 2013.
- EAM Investors disclosed 309 positions in Q2 2013, its first 13F filing on record.
Based on EAM Investors's 13F filing for Q2 2013, filed 2 Aug 2013.